Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial-Reference-Cited by-同舟云学术

Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial

Author:

Lim Young-Suk¹,Lee Yung Sang¹,Gwak Geum-Youn²,Byun Kwan Soo³,Kim Yoon Jun⁴,Choi Jonggi¹,An Jihyun¹,Lee Han Chu¹,Yoo Byung Chul⁵,Kwon So Young⁵

Affiliation:

1. Department of Gastroenterology; Liver Center, Asan Medical Center, University of Ulsan College of Medicine; Seoul Korea

2. Department of Medicine; Samsung Medical Center, Sungkyunkwan University School of Medicine; Seoul Korea

3. Department of Internal Medicine; Korea University College of Medicine; Seoul Korea

4. Department of Internal Medicine and Liver Research Institute; Seoul National University College of Medicine; Seoul Korea

5. Department of Internal Medicine; Konkuk University School of Medicine; Seoul Korea

Funder

Gilead Sciences

Korean National Health Clinical Research project, Ministry of Health & Welfare

Korean Health Technology R&D Project, Ministry of Health & Welfare

Proteogenomic Research Program through the National Research Foundation of Korea

Publisher

Wiley

Subject

Hepatology

Reference30 articles.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Guidelines for Prevention and Treatment of Chronic Hepatitis B;Journal of Clinical and Translational Hepatology;2021-09-28